PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.9186
-0.0555 (-5.70%)
At close: Dec 15, 2025, 4:00 PM EST
0.9350
+0.0164 (1.79%)
After-hours: Dec 15, 2025, 7:45 PM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $50.27 million as of December 15, 2025. Its market cap has decreased by -36.32% in one year.
Market Cap
50.27M
Enterprise Value
42.28M
1-Year Change
-36.32%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $50.27M, an increase of 10.45%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 53.30M | -12.58% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | 47.64M | 240.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |